Stock Earnings

Question 1

Báo cáo tài chính chính của United Laboratories International Holdings Ltd là gì?

Accepted Answer

Theo báo cáo tài chính mới nhất (Form-10K), United Laboratories International Holdings Ltd có tổng tài sản là $25,833, lợi nhuận ròng profit là $2,659

Question 2

Tỷ lệ tài chính chính của ULIHF là gì?

Accepted Answer

Tỷ lệ thanh khoản của United Laboratories International Holdings Ltd là 2.25, tỷ suất lợi nhuận ròng là 19.32, doanh thu trên mỗi cổ phiếu là $7.57.

Question 3

Doanh thu của United Laboratories International Holdings Ltd được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?

Accepted Answer

United Laboratories International Holdings Ltd largest revenue segment is Bulk Medicine, at a revenue of 6,909,415,147 in the most earnings release.For geography, China, including Hong Kong is the primary market for United Laboratories International Holdings Ltd, at a revenue of 12,051,782,799.

Question 4

United Laboratories International Holdings Ltd có lợi nhuận không?

Accepted Answer

yes, theo báo cáo tài chính mới nhất, United Laboratories International Holdings Ltd có lợi nhuận ròng profit là $2,659

Question 5

United Laboratories International Holdings Ltd có nợ không?

Accepted Answer

yes, United Laboratories International Holdings Ltd có nợ là 11,444

Question 6

United Laboratories International Holdings Ltd có bao nhiêu cổ phiếu đang lưu hành?

Accepted Answer

United Laboratories International Holdings Ltd có tổng cộng 1,817.02 cổ phiếu đang lưu hành

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	14,101	13,758	13,739	11,334	9,703	8,772
Revenue Growth (YoY)	1%	0%	21%	17%	11%	5%
Cost of Revenue	7,439	7,676	7,405	6,365	5,492	4,966
Gross Profit	6,661	6,082	6,334	4,968	4,211	3,806
Selling, General & Admin	2,375	2,341	2,381	2,354	2,628	2,291
Research & Development	942	890	757	593	465	339
Operating Expenses	3,107	3,042	3,053	2,862	3,051	2,555
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	3,806	3,288	3,344	2,006	1,202	882
Income Tax Expense	746	631	643	425	213	181
Net Income	3,062	2,659	2,701	1,581	988	702
Net Income Growth	5%	-2%	71%	60%	41%	10%
Shares Outstanding (Diluted)	1,816.93	1,816.81	1,817.02	1,819.73	1,840.04	1,765.96
Shares Change (YoY)	0%	0%	0%	-1%	4%	8%
EPS (Diluted)	1.68	1.46	1.48	0.86	0.53	0.39
EPS Growth	5%	-2%	71%	62%	35%	2%
Free Cash Flow	--	1,329	1,028	1,212	1,060	1,037
Free Cash Flow Per Share	--	0.73	0.56	0.66	0.57	0.58
Gross Margin	47.23%	44.2%	46.1%	43.83%	43.39%	43.38%
Operating Margin	25.2%	22.08%	23.88%	18.58%	11.94%	14.24%
Profit Margin	21.71%	19.32%	19.65%	13.94%	10.18%	8%
Free Cash Flow Margin	--	9.65%	7.48%	10.69%	10.92%	11.82%
EBITDA	--	3,654	3,846	2,658	1,779	1,864
EBITDA Margin	--	26.55%	27.99%	23.45%	18.33%	21.24%
D&A For EBITDA	--	615	565	552	620	614
EBIT	3,554	3,039	3,281	2,106	1,159	1,250
EBIT Margin	25.2%	22.08%	23.88%	18.58%	11.94%	14.24%
Effective Tax Rate	19.6%	19.19%	19.22%	21.18%	17.72%	20.52%

United Laboratories International Holdings Ltd (ULIHF) Price

ULIHF Stock Price Chart

ULIHF Income

Follow-Up Questions